Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
Sangjoon ParkYoon Jin ChaSang Hyun SuhIk Jae LeeKyu-Sung LeeChang-Ki HongJun Won KimPublished in: Journal of cancer research and clinical oncology (2019)
Tumor size, Simpson grade, and adjuvant RT were prognostic factors. The risk group-adapted approach can facilitate the selection of patients who may benefit from adjuvant RT for WHO grade I/II skull base meningiomas.